Related Experiment Videos
Solution Structure of the Human CD4 (403-419) Receptor Peptide
1Lehrstuhl für Struktur und Chemie der Biopolymere, Universität Bayreuth, Germany.
Journal of Biomedical Science
|November 1, 1996
Summary
The cytoplasmic domain of the human CD4 receptor, crucial for HIV-1 interaction, features an alpha-helix (403-419) potentially involved in binding Vpu and Nef proteins.
Area of Science:
- Biochemistry
- Structural Biology
- Virology
Background:
- The cytoplasmic tail of the CD4 receptor is critical for mediating interactions with human immunodeficiency virus type 1 (HIV-1) accessory proteins, specifically Vpu and Nef.
- Understanding the structural basis of these interactions is key to developing therapeutic strategies against HIV-1.
Purpose of the Study:
- To investigate the structural characteristics of a specific peptide segment (CD4 403-419) from the membrane-proximal region of the human CD4 receptor's cytoplasmic domain.
- To identify potential contact regions within the CD4 cytoplasmic tail involved in interactions with HIV-1 Vpu and Nef proteins.
Main Methods:
- Circular dichroism (CD) spectroscopy to determine secondary structure content.
- Nuclear magnetic resonance (NMR) spectroscopy, including chemical shift index analysis and nuclear Overhauser effect (NOE) analysis, to determine the precise location of secondary structural elements.
Main Results:
- The synthetic peptide CD4 (403-419) exhibited an average alpha-helical content of approximately 25%.
- NMR data localized an alpha-helical structure within the peptide sequence, spanning from Glutamine 403 (Gln403) to Arginine 412 (Arg412).
- This identified alpha-helix is amphipathic, suggesting a potential role in protein-protein interactions.
Conclusions:
- The membrane-proximal region of the CD4 cytoplasmic domain (residues 403-419) contains an amphipathic alpha-helix.
- This alpha-helical region is a likely candidate for the binding site of HIV-1 Vpu and Nef proteins.